Crispr Therapeutics: The Recent 40% Drop In Short Interest Indicates Deteriorating Bearish Sentiment
AI Summary
The article reports that short interest in Crispr Therapeutics has fallen by 40%, suggesting a reduction in bearish positioning. It discusses investor sentiment toward the biotechnology company.